醫藥廢棄物管理市場、機會、成長動力、產業趨勢分析與預測，2024-2032

2023 年全球藥品廢棄物管理市場價值為 47 億美元，預計 2024 年至 2032 年複合年成長率為 7.6%。 ，並增加醫療保健支出。

由於人口老化、慢性病激增以及醫學研究突破，藥品需求不斷成長，製藥業蓬勃發展，正在推動市場成長。例如，聯合國最近的一份報告預測，未來三十年，全球65歲以上人口將增加兩倍，到2050年達到16億，佔全球人口的16%以上。這種人口結構的變化預計將產生大量的藥品廢棄物，這凸顯出需要有效的廢棄物管理系統來處理過期、未使用或受污染的藥物。

醫療廢棄物管理方面的持續創新、加強監管審查、向永續實踐的轉變以及對公共衛生和安全的加強關注正在推動該行業的成長。此外，隨著全球對嚴格法規和合規標準的重視，製藥公司和醫療保健提供者正在採用強力的廢棄物管理實務。監管機構強調安全處置製藥廢棄物，以減輕環境危害和公共衛生風險，從而增加對經過認證的廢棄物管理服務和技術的需求。

醫療機構和製藥公司擴大轉向專業的第三方提供者來滿足其廢棄物管理需求。這種轉變是由於廢棄物法規的複雜性和處理危險物質所需的專業知識，刺激了廢棄物管理服務業的成長。

整個製藥廢棄物管理產業根據廢棄物類型、處理地點、廢棄物產生者和地區進行細分。

2023年，包括一般藥品廢棄物、包裝廢棄物和其他無害材料在內的無害廢棄物部分產生了最高收入，達36億美元。這一成長是由非危險廢物的增加帶動的，包括需要妥善處置的未使用的、過期的和非處方藥物。隨著藥物消耗的增加，對高效無害廢棄物管理系統的需求也增加。無害廢棄物處理方法的成本效益有助於醫療機構、藥局和家庭採取適當的廢棄物管理做法。

2023 年，異地處理領域以 59% 的主導佔有率引領市場。異地處理顯著降低了醫療機構內部處理和加工製藥廢棄物的風險。透過將廢棄物轉移到專門的處理中心，組織可以降低污染、接觸有害物質和潛在事故的風險。這些場外設施配備了必要的專業知識和基礎設施，可安全地管理和處理不同類型的製藥廢棄物。他們經常利用先進的技術和設備，例如焚燒、化學處理和廢物能源轉化，這對較小的醫療機構來說可能不可行。他們處理大量廢棄物並提供專業服務的能力進一步擴大了對場外處理的需求。

2023年，北美醫藥廢棄物管理市場規模將達到17億美元，預計2024年至2032年複合年成長率為7%。自動廢棄物追蹤、先進的焚燒方法和複雜的化學處理等創新正在提高製藥廢棄物管理的效率和安全性。這些技術的採用不僅可以促進市場成長，還可以確保更有效、更合規的解決方案。此外，企業社會責任（CSR）措施以及對永續實踐的投資正在塑造區域市場前景。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 醫療保健支出和藥物消費不斷增加
    • 製藥業的成長
    • 廢棄物管理的技術進步
    • 關注醫療機構標準
  • 產業陷阱與挑戰
    • 廢棄物管理解決方案成本高昂
    • 廢棄物分類面臨的挑戰
• 成長潛力分析
• 技術景觀
• 監管環境
• 波特的分析
• PESTEL分析
• 處理藥品廢棄物的方法
• 價值鏈分析
• 差距分析
• 未來市場趨勢

第 4 章：競爭格局

• 介紹
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按廢棄物類型，2021 - 2032 年

• 主要趨勢
• 危險廢棄物
  • 傳染性廢棄物
  • 化學廢棄物
  • 放射性廢棄物
  • 其他危險廢棄物
• 無害廢棄物
  • 一般醫藥廢棄物
  • 包裝廢棄物
  • 其他無害廢棄物

第 6 章：市場估計與預測：按治療地點分類，2021 - 2032 年

• 主要趨勢
• 異地處理
• 現場治療

第 7 章：市場估計與預測：按垃圾產生者分類，2021 - 2032 年

• 主要趨勢
• 醫院和診所
• 製藥和生物技術公司
• 藥局
• 其他廢棄物產生者

第 8 章：市場估計與預測：按地區，2021 - 2032

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第 9 章：公司簡介

• Biomedical Waste Solutions
• BWS Incorporated
• Casella Waste Systems, Inc.
• Clean Harbors
• Cleanaway Waste Management Limited
• EcoMed Services
• Gamma Waste Services
• GRP and Associates, Inc.
• Hazardous Waste Experts
• MedPro Disposal
• REMONDIS SE and Co. KG
• Reworld Waste, LLC.
• Stericycle, Inc.
• VEOLIA ENVIRONNEMENT
• Waste Management, Inc.

The Global Pharmaceutical Waste Management Market was valued at USD 4.7 billion in 2023 and is projected to grow at a CAGR of 7.6% from 2024 to 2032. This growth is linked to advancements in waste treatment, heightened environmental concerns, more drug recalls and expired medications, and increasing healthcare expenditures.

Booming pharma sector, driven by rising demand for medications due to an aging population, a surge in chronic diseases, and breakthroughs in medical research, is pushing market growth. For example, a recent United Nations (UN) report forecasts that the global population aged 65 and over will triple in the next three decades, reaching 1.6 billion by 2050, which will constitute over 16% of the global populace. This demographic shift is expected to generate larger volumes of pharmaceutical waste, underscoring the need for efficient waste management systems to handle expired, unused, or contaminated drugs.

Continuous innovations in medical waste management, heightened regulatory scrutiny, a shift towards sustainable practices, and an intensified focus on public health and safety are driving the industry's growth. Additionally, with a global emphasis on stringent regulations and compliance standards, pharmaceutical companies and healthcare providers are adopting robust waste management practices. Regulatory bodies emphasize the safe disposal of pharmaceutical waste to mitigate environmental harm and public health risks, increasing demand for certified waste management services and technologies.

Healthcare facilities and pharmaceutical companies are increasingly turning to specialized third-party providers for their waste management needs. This shift is due to the intricate nature of waste regulations and the expertise required in handling hazardous materials, spurring growth in the waste management service industry.

The overall pharmaceutical waste management industry is segmented based on waste type, treatment site, waste generator, and region.

In 2023, the non-hazardous waste segment, encompassing general pharmaceutical waste, packaging waste, and other non-hazardous materials, generated the highest revenue of USD 3.6 billion. The growth is led by an uptick in non-hazardous waste, including unused, expired, and over-the-counter medications necessitating proper disposal. As medication consumption rises, so does the demand for efficient non-hazardous waste management systems. The cost-effectiveness of non-hazardous waste disposal methods facilitates proper waste management practices across healthcare facilities, pharmacies, and households.

In 2023, the offsite treatment segment led the market with a commanding share of 59%. Offsite treatment significantly reduces the risks tied to handling and processing pharmaceutical waste within healthcare settings. By transferring waste to specialized treatment centers, organizations can mitigate risks of contamination, exposure to hazardous substances, and potential accidents. These offsite facilities, equipped with the necessary expertise and infrastructure, can safely manage and treat diverse pharmaceutical waste types. They often utilize advanced technologies and equipment, such as incineration, chemical treatment, and waste-to-energy conversion, which may be unfeasible for smaller healthcare facilities. Their capability to process large waste volumes and offer specialized services further amplifies the demand for offsite treatment.

In 2023, North America pharmaceutical waste management market accounted for a substantial USD 1.7 billion and is projected to grow at a CAGR of 7% from 2024 to 2032. The region is leading the charge in adopting cutting-edge waste management technologies. Innovations like automated waste tracking, advanced incineration methods, and sophisticated chemical treatments are bolstering the efficiency and safety of pharmaceutical waste management. The adoption of these technologies not only enhances market growth but also ensures more effective and compliant solutions. Additionally, the Corporate Social Responsibility (CSR) initiatives, along with investments in sustainable practices is shaping the regional market outlook.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising healthcare expenditures and drug consumption
    • 3.2.1.2 Growth in the pharmaceutical industry
    • 3.2.1.3 Technological advancements in waste management
    • 3.2.1.4 Focus on healthcare facility standards
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High costs of waste management solutions
    • 3.2.2.2 Challenges in waste segregation
• 3.3 Growth potential analysis
• 3.4 Technology landscape
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis
• 3.8 Methods of treating pharmaceutical waste
• 3.9 Value chain analysis
• 3.10 Gap analysis
• 3.11 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Waste Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Hazardous waste
  • 5.2.1 Infectious waste
  • 5.2.2 Chemical waste
  • 5.2.3 Radioactive waste
  • 5.2.4 Other hazardous wastes
• 5.3 Non-hazardous waste
  • 5.3.1 General pharmaceutical waste
  • 5.3.2 Packaging waste
  • 5.3.3 Other non-hazardous wastes

Chapter 6 Market Estimates and Forecast, By Treatment Site, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Offsite treatment
• 6.3 Onsite treatment

Chapter 7 Market Estimates and Forecast, By Waste Generator, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals and clinics
• 7.3 Pharmaceuticals and biotech companies
• 7.4 Pharmacies
• 7.5 Other waste generators

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Biomedical Waste Solutions
• 9.2 BWS Incorporated
• 9.3 Casella Waste Systems, Inc.
• 9.4 Clean Harbors
• 9.5 Cleanaway Waste Management Limited
• 9.6 EcoMed Services
• 9.7 Gamma Waste Services
• 9.8 GRP and Associates, Inc.
• 9.9 Hazardous Waste Experts
• 9.10 MedPro Disposal
• 9.11 REMONDIS SE and Co. KG
• 9.12 Reworld Waste, LLC.
• 9.13 Stericycle, Inc.
• 9.14 VEOLIA ENVIRONNEMENT
• 9.15 Waste Management, Inc.